Literature DB >> 8430215

Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events.

S Hoyer1.   

Abstract

1. Early-onset dementia of Alzheimer type (EODAT; AD) and late-onset dementia of Alzheimer type (LODAT; SDAT) are heterogenous in origin. 2. A common superordinate pathobiochemical principle in the etiopathogenesis of both types of dementia is neuronal energy failure with subsequent abnormalities in cellular Ca2+ homeostasis and glucose-related amino acid metabolism. 3. These metabolic abnormalities are assumed to occur first at axodendritic terminals of the acetylcholinergic-glutamatergic circuit and to cause morphological damage at synaptic sites. 4. Metabolic stress and structural damage at synaptic sites may induce enhanced formation of APP and its cleavage product amyloid. 5. Energy-metabolism related abnormalities along with functional and structural changes at synaptic sites of the acetylcholinergic-glutamatergic circuit may precede the formation of amyloid in DAT brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430215     DOI: 10.1016/0278-5846(93)90043-r

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

1.  Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes.

Authors:  M Hirano; A Shtilbans; R Mayeux; M M Davidson; S DiMauro; J A Knowles; E A Schon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

2.  Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease.

Authors:  R E Davis; S Miller; C Herrnstadt; S S Ghosh; E Fahy; L A Shinobu; D Galasko; L J Thal; M F Beal; N Howell; W D Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

3.  Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide.

Authors:  Mark A Lovell; Shuling Xiong; William R Markesbery; Bert C Lynn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

4.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

5.  Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease.

Authors:  Bert C Lynn; Jianquan Wang; William R Markesbery; Mark A Lovell
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 6.  Abnormal mitochondrial dynamics and neurodegenerative diseases.

Authors:  Bo Su; Xinglong Wang; Ling Zheng; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Biochim Biophys Acta       Date:  2009-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.